- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Primary Glomerulonephritis in United States
Total 25346 results
-
Celldex TherapeuticsTerminatedC3 Glomerulonephritis | Dense Deposit Disease | Membranoproliferative Glomerulonephritis Type IIUnited States
-
Mayo ClinicCompletedGlomerulonephritis, MembranoproliferativeUnited States
-
Columbia UniversityAlexion PharmaceuticalsCompletedDense Deposit Disease | Membranoproliferative GlomerulonephritisUnited States
-
Fernando FervenzaCompleted
-
Mayo ClinicGenentech, Inc.CompletedFibrillary GlomerulonephritisUnited States
-
Alexion PharmaceuticalsCompletedC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit DiseaseUnited Kingdom, United States
-
Apellis Pharmaceuticals, Inc.AvailableC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States
-
National Center for Research Resources (NCRR)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Ohio...CompletedIGA GlomerulonephritisUnited States
-
University of IowaWithdrawn
-
University of IowaWithdrawn
-
Mayo ClinicGenentech, Inc.CompletedMembranous NephropathyUnited States
-
Mayo ClinicGenentech, Inc.Completed
-
AlexionTerminatedIC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Membranoproliferative GlomerulonephritisUnited States, Australia, Belgium, Italy, Netherlands
-
National Institute of Diabetes and Digestive and...CompletedMembranous Glomerulonephritis | Lupus Membranous NepropathyUnited States
-
Icahn School of Medicine at Mount SinaiCompleted
-
St. Joseph's Hospital and Medical Center, PhoenixTerminated
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Australia, Brazil, Czechia, France, Italy, Korea, Republic of, Netherlands, Spain, Switzerland, United Kingdom
-
Apellis Pharmaceuticals, Inc.Active, not recruitingLupus Nephritis | IgA Nephropathy | Membranous Nephropathy | C3 Glomerulonephritis | Dense Deposit DiseaseUnited States
-
NephroNet, Inc.MallinckrodtActive, not recruitingFibrillary GlomerulonephritisUnited States
-
Aravive, Inc.TerminatedIgA NephropathyUnited States, Ukraine
-
Visterra, Inc.CompletedImmunoglobulin A Nephropathy | IgA Nephropathy | IgAN - IgA NephropathyUnited States
-
Mayo ClinicWithdrawnIdiopathic Membranous NephropathyUnited States
-
Mayo ClinicNot yet recruitingFibrillary GlomerulonephritisUnited States
-
Imperial College Healthcare NHS TrustCompletedGlomerulonephritis, MembranousUnited Kingdom
-
Apellis Pharmaceuticals, Inc.Active, not recruitingRenal Transplant | C3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative... and other conditionsUnited States, Australia, Austria, United Kingdom, Brazil, Argentina, France, Italy, Netherlands, Spain, Switzerland
-
Mayo ClinicMallinckrodtCompletedIdiopathic Membranous NephropathyUnited States, Canada
-
Baylor College of MedicineWithdrawn
-
Mayo ClinicRecruitingProliferative Glomerulonephritis With Monoclonal IgG DepositsUnited States
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Spain, France, Germany, United Kingdom, Netherlands, Brazil, Israel, Japan, Australia, Austria, Italy, Switzerland, Korea, Republic of, Czechia, Belgium, Argentina, Canada, Poland
-
Mayo ClinicColumbia University; Genentech, Inc.; Stanford University; Ohio State University; Bioge... and other collaboratorsCompleted
-
University of California, DavisCompletedHealthy Subjects | Immunoglobulin A NephropathyUnited States
-
Gilead SciencesCompletedLupus Membranous NephropathyUnited States
-
Mayo ClinicUniversity Health Network, Toronto; National Institute of Diabetes and Digestive... and other collaboratorsCompletedPrimary Focal Segmental GlomerulosclerosisCanada, United States
-
National Institute of Arthritis and Musculoskeletal...CompletedLupus Nephritis | Glomerulonephritis, MembranoproliferativeUnited States
-
The Rogosin InstituteWeill Medical College of Cornell UniversityCompleted
-
GlaxoSmithKlineCompletedGlomerulonephritis, MembranousUnited Kingdom
-
National Institute of Diabetes and Digestive and...RecruitingProteinuria | Nephrotic Syndrome | Autoimmune Disease | Glomerular Disease | Membranous GlomerulonephritisUnited States
-
BeiGeneRecruitingPrimary Membranous NephropathyChina, United Kingdom, United States
-
Otsuka Pharmaceutical Development & Commercialization...Enrolling by invitationImmunoglobulin A NephropathyUnited States
-
Rigel PharmaceuticalsCompletedIGA NephropathyUnited States, United Kingdom, Hong Kong, Taiwan, Austria, Germany
-
Cerium Pharmaceuticals, Inc.RecruitingPrimary Membranous NephropathyUnited States, India, Canada
-
Vera Therapeutics, Inc.RecruitingIgA Nephropathy | Berger DiseaseUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Active, not recruitingImmunoglobulin A NephropathyUnited States
-
Ohio State UniversityMallinckrodtWithdrawnSLE Glomerulonephritis Syndrome, WHO Class VUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedIgA NephropathyUnited States, Japan, United Kingdom
-
Novartis PharmaceuticalsRecruitingPrimary IgA NephropathyJapan, Korea, Republic of, United States, Denmark, France, Taiwan, Belgium, Israel, Thailand, Germany, India, Czechia, Malaysia, Argentina, Singapore, China, Australia, Norway, Turkey, United Kingdom, Brazil, Hong Kong, Netherlands, C... and more
-
Hoffmann-La RocheActive, not recruitingPrimary Membranous NephropathyUnited States, China, Spain, Argentina, Brazil, France, Italy, Russian Federation, Israel, Poland, Turkey, Ukraine
-
Calliditas Therapeutics ABCompletedPrimary IgA NephropathyBelgium, United Kingdom, Denmark, Finland, Sweden, Germany, Spain, Italy, Czech Republic, Netherlands
-
Columbia UniversityNovartis PharmaceuticalsTerminatedDiabetic Nephropathy | Focal Segmental Glomerulosclerosis | IgA Nephropathy | Glomerulonephritis, Membranous | Hypertensive Nephrosclerosis | Proteinuric Kidney Disease | Glomerulopathy (Obesity-associated)United States
-
Genzyme, a Sanofi CompanyCompletedPrimary Focal Segmental GlomerulosclerosisUnited States, Brazil, Germany, Italy, Spain